Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA

Pioneering Technology Leads to First 3-Tesla, Cryogen-Free MRI Benchtop Scanner

By BiotechDaily International staff writers
Posted on 06 Mar 2013
Image: The new benchtop 3T MRI scanner (left) located near other laboratory equipment (Photo courtesy of MR Solutions).
Image: The new benchtop 3T MRI scanner (left) located near other laboratory equipment (Photo courtesy of MR Solutions).
Applying technological advances related to supercooling has enabled the development of a superior and more convenient 3-Tesla MRI scanner for biological and medical research laboratories.

The new “3T MRI” benchtop scanner, developed by MR Solutions (Guildford, UK), provides superior soft tissue contrast and molecular imaging capability as well as a breakthrough design that enables it to be conveniently fitted into an existing laboratory.

The scanner includes two major advances. First, the usual MRI liquid helium cooling system has been replaced by using a revolutionary magnet design incorporating new superconducting wire. Through a technology solution pioneered by MR Solutions and its magnet partner, this enables the use of a standard low-temperature cryocooler to cool the magnet to the 4 Kelvin required to achieve superconductivity. Second, the 3T MRI scanner does not require that it be isolated in a “Faraday cage” as its stray magnetic field is only a few centimetres and will not interfere with other equipment in a laboratory. The elimination of the helium cooling system has allowed an optimal installation of an additional solenoid to counter the stray magnetic field. These advances have also dramatically reduced the cost of this powerful scanner to make it highly competitive.

Professor Van der Linden from Bio Imaging Laboratory of the University of Antwerp commented, “This new scanner is a breakthrough and will provide us with the extra scanning power we need within our existing facilities. We can just wheel it in without knocking down any walls and without having to install a costly helium system and the safety system that goes with it. And as its stray magnetic field is so small, we can put other sensitive laboratory equipment and scanners close by for much better work flow.”

Related Links:
MR Solutions



Channels

Genomics/Proteomics

view channel
Image: Cancer cells, left, were pretreated with a drug that blocks the ERK signal, and right, without the pretreatment. Top cells are untreated, while the bottom ones are stimulated (Photo courtesy of the Weizmann Institute of Science).

Prevention of ERK Nuclear Translocation Blocks Cancer Proliferation in Animal Models

A team of cell biologists has shown that the cancer promoting effects of ERK dysregulation can be blocked by low molecular weight drugs that prevent translocation of this kinase from the cells' cytoplasm... Read more

Drug Discovery

view channel
Image: Star-like glial cells in red surround alpha-beta plaques in the cortex of a mouse with a model of Alzheimer\'s disease (Photo courtesy of Strittmatter laboratory/Yale University).

Experimental Cancer Drug Reverses Symptoms in Mouse Model of Alzheimer's Disease

An experimental, but clinically disappointing drug for treatment of cancer has been found to be extremely effective in reversing the symptoms of Alzheimer's disease (AD) in a mouse model.... Read more

Biochemistry

view channel
Image:  Model depiction of a novel cellular mechanism by which regulation of cryptochromes Cry1 and Cry2 enables coordination of a protective transcriptional response to DNA damage caused by genotoxic stress (Photo courtesy of the journal eLife, March 2015, Papp SJ, Huber AL, et al.).

Two Proteins Critical for Circadian Cycles Protect Cells from Mutations

Scientists have discovered that two proteins critical for maintaining healthy day-night cycles also have an unexpected role in DNA repair and protecting cells against genetic mutations that could lead... Read more

Business

view channel

NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer

The University of Texas MD Anderson Cancer Center (Houston, TX, USA) and NanoString Technologies, Inc. (Seattle, WA, USA) will partner on development of a revolutionary new type of assay—simultaneously profiling gene and protein expression, initially aiming to discover and validate biomarker signatures for immuno-oncology... Read more
 

Events

21 Apr 2015 - 23 Apr 2015
21 Apr 2015 - 23 Apr 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.